Chamber and committees

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

Written questions must be answered within 10 working days (20 working days during recess)
Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Filter your results Hide all filters

Displaying 79 questions Show Answers

Order by |

Question reference: S7W-04063

Asked by: Adam Harley, MSP for Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: Wednesday, 07 October 2026
Current Status: Answer expected on 4 November 2026

To ask the Scottish Government what discussions it has had with Biogen to facilitate the resubmission of Skyclarys (omaveloxolone) to the Scottish Medicines Consortium for consideration for use within NHS Scotland, and what specific action it has taken as a result.

Question reference: S7W-04069

Asked by: Adam Harley, MSP for Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: Wednesday, 07 October 2026
Current Status: Answer expected on 4 November 2026

To ask the Scottish Government what steps it is taking to ensure that NHS Scotland is prepared for future treatments for Friedreich’s ataxia, including those that might become available for children and young people.

Question reference: S7W-04066

Asked by: Adam Harley, MSP for Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: Wednesday, 07 October 2026
Current Status: Answer expected on 4 November 2026

To ask the Scottish Government what assessment it has made of any barriers that would need to be addressed by Biogen before Skyclarys (omaveloxolone) could be resubmitted to the Scottish Medicines Consortium for consideration for use within NHS Scotland.

Question reference: S7W-04067

Asked by: Adam Harley, MSP for Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: Wednesday, 07 October 2026
Current Status: Answer expected on 4 November 2026

To ask the Scottish Government how many applications for access to Skyclarys (omaveloxolone) have been made through the Patient Access to Care Services (PACS) Tier 2 process in each NHS board area since the medicine became available in the UK and, for each NHS board area, how many applications have been approved.

Question reference: S7W-04068

Asked by: Adam Harley, MSP for Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: Wednesday, 07 October 2026
Current Status: Answer expected on 4 November 2026

To ask the Scottish Government whether its Access to New Medicines Horizon Scanning Advisory Board is currently considering Friedreich’s ataxia and emerging treatments for the condition, and, if so, which treatments are being monitored.

Question reference: S7W-03616

Asked by: Adam Harley, MSP for Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: Thursday, 24 September 2026
Current Status: Answered by Kirsten Oswald on 6 October 2026

To ask the Scottish Government whether it plans to introduce further regulation on the sale of fireworks to prevent antisocial behaviour and negative impacts on local residents.

While the law covering the sale of fireworks is mainly reserved, the Scottish Government has taken steps to strengthen the law around access to, and use of, fireworks. The Fireworks and Pyrotechnic Articles (Scotland) Act 2022, introduced measures intended to reduce harmful and antisocial use of fireworks and pyrotechnic articles, while supporting the safe and responsible enjoyment of fireworks. This includes: a proxy purchase and supply offence to under 18s; a statutory aggravation for emergency workers; introduction of pyrotechnic offences and introduction of Firework Control Zones.

At this time, the Scottish Government has no plans to introduce legislation on the sale of fireworks.

The UK Government is running, until 7 October, a consultation on fireworks and pyrotechnics in the UK. This can be found at: Fireworks and pyrotechnics in the UK - GOV.UK.

Question reference: S7W-03854

Asked by: Adam Harley, MSP for Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: Thursday, 01 October 2026
Current Status: Answer expected on 29 October 2026

To ask the Scottish Government what assessment it has made of Recommendation 16 of the Thirlwall Inquiry, and whether it considers that existing arrangements in Scotland provide healthcare whistle-blowers with sufficiently independent support and oversight where concerns have not been adequately addressed by an NHS board.

Question reference: S7W-03869

Asked by: Adam Harley, MSP for Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: Thursday, 01 October 2026
Current Status: Answer expected on 29 October 2026

To ask the Scottish Government what mechanisms exist to prevent an NHS manager who has been found responsible for serious misconduct or patient safety failings from moving into a management role in another NHS board, and whether it will review these arrangements in light of Recommendation 13 of the Thirlwall Inquiry.

Question reference: S7W-03857

Asked by: Adam Harley, MSP for Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: Thursday, 01 October 2026
Current Status: Answer expected on 29 October 2026

To ask the Scottish Government what safeguards are currently in place in neonatal units to control and record access to insulin, and whether, in response to Recommendation 2 of the Thirlwall Inquiry, it will introduce digital access controls and monitoring of insulin storage.

Question reference: S7W-03866

Asked by: Adam Harley, MSP for Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: Thursday, 01 October 2026
Current Status: Answer expected on 29 October 2026

To ask the Scottish Government whether, in light of Recommendation 10 of the Thirlwall Inquiry, it will consider establishing a national panel of independent clinical and other experts that NHS boards could call upon to conduct rapid, independent investigations where concerns emerge about possible harm being caused to patients.